Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Off Script: A Pharma Manufacturing Podcast

Off Script: A Pharma Manufacturing Podcast artwork

The Changing Economics of Pharma Manufacturing

Oct 20, 202620 minAudioEpisode 148
ShareXLinkedInFacebookWhatsAppEmail

Increased regulatory scrutiny, onshoring efforts, and supply chain vulnerabilities are reshaping how life sciences manufacturers are making investment decisions across the industry. Pharma manufacturers are weighing facility locations, workforce availability, and manufacturing costs while looking for ways to strengthen supply chain resilience and improve operational efficiency. In this episode of Off Script, the third in our series exploring CRB’s Horizons: Life Sciences 2026 report, we spoke with Christa Myers, senior fellow of aseptic and sterile products at CRB and a co-author of the report. The conversation explored how manufacturers are evaluating established and emerging biopharma hubs, developing workforces to support advanced manufacturing technologies, and addressing supply chain risks. Myers also discussed how company size impacts decisions on investment and modernization, and the growing significance of process intensification to help manufacturers improve efficiency while keeping costs under control.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Preparing the Pharma Workforce for Manufacturing Growth

    Nov 17, 202619 minAudio

    Ongoing investments to expand pharmaceutical manufacturing in the U.S. are creating demand for skilled workers, making it increasingly important to strengthen the talent pool to meet industry need. At the same time,...

    Credit the people on this episode

  2. How Engineered Yeast Could Reduce Biomanufacturing Costs

    Nov 10, 202624 minAudio

    In biomanufacturing, recovering intracellular bioproducts after fermentation can be a costly and energy-intensive process. To address this challenge, researchers are developing new approaches to reduce energy...

    Credit the people on this episode

  3. Adapting Drug Development in a Tighter Funding Environment

    Nov 3, 202616 minAudio

    Tighter funding conditions are putting greater pressure on emerging biotech to reach key development milestones quickly while managing limited budgets. That environment is also changing what sponsors expect from their...

    Credit the people on this episode

  4. How Manufacturers Manage Pipelines in an Uncertain Market

    Oct 27, 202630 minAudio

    Despite ongoing geopolitical and regulatory pressures, life sciences manufacturers continue to invest in their product pipelines while also being more deliberate about long-term portfolio decisions. As interest in...

    Credit the people on this episode

  5. Solutions Spotlight: Applying Flow Chemistry to Complex Pharmaceutical Manufacturing

    Oct 23, 202625 minAudio

    Pharmaceutical manufacturers working with hazardous and difficult-to-control chemical reactions face challenges in managing process safety, heat transfer, and reaction conditions. Flow chemistry offers an alternative to...

    Credit the people on this episode